Einfluß der Hibernation auf die Vermehrung und Ausbreitung von Virus Aujeszky

Zusammenfassung Die artifizielle Hibernation hemmt und verzögert die Vermehrung und die Ausbreitung von Virus Aujeszky im ZNS. peripher infizierter Kaninchen erheblich. Hierdurch findet die frühere Beobachtung 1, wonach die Dauer der Inkubationsperiode und des Krankheitsverlaufes des M. Aujeszky bei Kaninchen beträchtlich verlängert ist, eine hinreichende Erklärung.     

Kinetics of lactose fermentation in milk with kombucha starter

The aim of this research was to investigate the effect of new, non-conventional starter culture on the kinetics of the lactose transformation during milk fermentation by kombucha, at pH 5.8; 5.4; 5.1; 4.8; and 4.6, at two different temperatures 37 °C and 42 °C. Milk fermentation at 42 °C lasted significantly shorter (about 5 h, 30 min) compared to the fermentation at 37 °C. Changes of lactose concentration at the both temperatures are consisting of two retaining stages and very steep decline in–between. The analysis of the rate curves showed that the reaction rate passes through the maximum after 9 h, 30 min at 37 °C and after 4 h at 42 °C. The sigmoidal saturation curve indicates a complex kinetics of lactose fermentation by kombucha starter.     

Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress,ethanol, indomethacin,and capsaicin neurotoxicity

Very recently, the integrity of capsaicin somatosensory neurons and their protection were suggested to be related to the activity in nociception of a newly discovered 15-amino acid peptide, BPC 157, shown to have strong beneficial effect on intestinal and liver lesions. Therefore, from this viewpoint, we have studied the gastroprotective effect of the pentadecapeptide BPC 157, on gastric lesions produced in rats by 96% ethanol, restraint stress, and indomethacin. The possible involvement of sensory neurons in the salutary actions of BPC 157 (10µg/kg, 10 ng/kg intraperitoneally) was studied with capsaicin, which has differential effects on sensory neurons: a high dose in adult (125 mg/kg subcutaneously, 3 months old) or administration (50 mg/kg subcutaneously) to neonatal animals (age of the 7 days) destroys sensory fibers, whereas a low dose (500µg/kg intraperitoneally) activates neurotransmitter release and protective effects on the mucosa. In the absence of capsaicin, BPC 157 protected gastric mucosa against ethanol, restraint, and indomethacin application. In the presence of neurotoxic doses of capsaicin, the negative influence of capsaicin on restraint, ethanol, or indomethacin lesions consistently affected salutary activity of BPC 157. However, BPC 157 protection was still evident in the capsaicin-treated rats (either treated as adults or as newborns) in all of these assays. Interestingly, after neonatal capsaicin treatment, a complete abolition of BPC gastroprotection was noted if BPC 157 was applied as a single nanogram-regimen, but the mucosal protection was fully reversed when the same dose was used daily. In line with the excitatory dose of capsaicin the beneficial effectiveness of BPC 157 appears to be increased as well. Taken together, these data provide evidence for complex synergistic interaction between the beneficial effectiveness of BPC 157 and peptidergic sensory afferent neuron activity.     

Pharmakologisch aktive polymere, 8.Poly[2-(methylsulfinyl)äthylacrylat]e und ihre vermittelnde wirkung auf die transkutane resorption von pharmaka

Poly[2-(methylsulfinyl)ethyl acrylate] ( 2a ) and poly[2-(methylsulfinyl)ethyl methacrylate] ( 2b ) were synthesized in order to examine their ability to enhance the penetration of pharmaceutical agents through the skin. 2b improved the absorption of the two phosphoric acid esters Dimethoat® and Paraoxon® as well as that of p-aminohippuric acid by an amount which was comparable to the effect shown by DMSO. A smaller effect was observed in the case of dinitrochlorobenzene. The dermal absorption of isoprenalin sulfate was not influenced. Both polymers showed a good local compatibility and 2b no acute common toxicity at systemic levels of application. The characteristic garlic-like odor of DMSO was not observed after either local or systemic application of the polymers.     

Bcl-2 and MALT1 genes are not involved in the oncogenesis of uterine tumors resembling ovarian sex cord tumors

Uterine tumors resembling ovarian sex cord tumors (UTROSCT) are rare entities. They were described by Clement and Scully in 1976 who classified them into groups I and II. Group I comprises typical endometrial stromal neoplasms with focal areas resembling ovarian sex cord elements and group II are predominantly or completely composed of ovarian sex cord-like elements. We report a case of UTROSCT type II with cytogenetic analysis. The tumor occurred in a 76-year-old woman who presented with vaginal bleeding. The tumor was lobulated, firm, yellow and histologically composed of sex cord-like elements. Tumor cells expressed vimentin, CD10, CD99 and alpha-actin. Cytogenetic analysis in a previously reported case detected translocation t(4;18)(q21.1;q21.3) in the majority of cells. Bcl-2 and MALT1 genes are located at or near the translocation breakpoints, and the aim of this study was to determine whether these genes were involved in chromosomal translocation or tumorigenesis. We did not find IgH translocation or the most common MALT translocations. Bcl-2 was also not involved in this oncogenesis.     

Topical Glycopirrolate for the Management of Hyperhidrosis in Herpetic Neuralgia

Herpes zoster is a relapse of varicella. In certain cases, long-term pain and hyperhidrosis have been noted. Appearance of herpes zoster during pregnancy is infrequent. We described hyperhidrosis and pain treatment using glycopirrolate cream in a pregnant woman with herpetic neuralgia. A 32 year old woman, 21 weeks pregnant with second child, complained to her gynecologist of the appearance of a vesicular rash on the left half of the forehead that progressed toward her left eyelid, accompanied by lancinating pain, allodynia, hyperhidrosis and small edema, blepharitis and conjunctivitis. Following clinical and laboratory tests, she was diagnosed with herpes zoster ophtalmicus. Aciclovir therapy was administered 800 mg orally five times daily for seven days. Pain therapy was initiated with amitriptilline. We discontinued amitriptilline therapy after 10 days because of appearance of unwanted side effects. After skin changes ceased, we introduced Lidocaine patch into pain therapy which reduced the allodynia, but not the lancinating pain and hyperhidrosis. At that time we began using glycopirrolate cream which reduced pain intensity by 28.5% within 24 hours, and completely eliminated hyperhidrosis. After 48 hours of use, the pain completely disappeared. During the Glycopirrolate cream therapy, there were no side effects. This is a first report to document that a topical Glycopirrolate cream has a beneficial effect in a patient with hyperhidrosis and herpetic neuralgia.     

BPC-157,一种胃十五肽的抗焦虑作用:休克探查/埋藏试验和明暗试验(英文)

AIM: To study anxiolytic effect of a gastric pentade-capeptide, BPC-157. METHODS: In shock probe/burying test, pentadecapeptide BPC-157 (10 μg/kg, 10ng/kg, ip), diazepam (0.075, 0.0375 mg/kg, ip),and an equivolume of saline (5 mL/kg, ip) were givenat 30 min prior test. In light/dark test, the same dosageof diazepam, BPC-157, and saline were given at 45 minPrior procedure. RESULTS: Shock probe/buryingtest: rats treated with either diazepam or pentadecapeptideBPC-157 were much less afraid after the shock: almost     

Effective therapy of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157.

We report complete transection of major muscle and the systemic peptide treatment that induces healing of quadriceps muscle promptly and then maintains the healing with functional restoration. Initially, stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, M.W. 1419, PL-10, PLD-116, PL 14736 Pliva, Croatia; in trials for inflammatory bowel disease; wound treatment; no toxicity reported; effective alone without carrier) also superiorly accelerates the healing of transected Achilles tendon. Regularly, quadriceps muscle completely transected transversely 1.0 cm proximal to patella presents a definitive defect that cannot be compensated in rat. BPC 157 (10 microg, 10 ng, 10 pg/kg) is given intraperitoneally, once daily; the first application 30 min posttransection, the final 24 h before sacrifice. It consistently improves muscle healing throughout the whole 72-day period. Improved are: (i) biomechanic (load of failure increased); (ii) function (walking recovery and extensor postural thrust/motor function index returned toward normal healthy values); (iii) microscopy/immunochemistry [i.e., mostly muscle fibers connect muscle segments; absent gap; significant desmin positivity for ongoing regeneration of muscle; larger myofibril diameters on both sides, distal and proximal (normal healthy rat-values reached)]; (iv) macroscopic presentation (stumps connected; subsequently, atrophy markedly attenuated; finally, presentation close to normal noninjured muscle, no postsurgery leg contracture). Thus, posttransection healing-consistently improved-may suggest this peptide therapeutic application in muscle disorders.     

Treatment of osteoporotic fractures of the spine

Osteoporosis is a skeletal disease characterized by reduced bone strength due to the loss of bone mass, structural disproportion and reduced calcium level as well as changes in the bone structure caused by trabecular deficit. The loss of bone mass in the vertebrae leads to an increased risk of fractures. Osteoporotic vertebral fractures are two to three times more frequent than hip fractures, especially in women. Osteoporotic compressive fractures of the spine mostly occur in the middle and lower thoracic spine and in the thoracolumbar spine. Common consequences of fractures include long-term pains, decrease in the height and spinal deformity, which significantly correlate with disorders in the gait and mobility, reduced pulmonary function, loss of appetite and in the end increased mortality. Clinical picture in acute conditions manifests itself as a sudden pain in the back following minimal trauma but also often without any trauma at all. Diagnostics is based on a detailed medical history and a thorough clinical examination. Radiological diagnosis relies on standard x-rays. In case of clinical indication (differential diagnosis of tumor or spondylitis, neurological weakness) CT and/or MR imaging is performed. The approach to the treatment of osteoporotic fractures of the spine is individual and is based upon the medical history, localization of symptoms and correlation of the clinical examination with the radiological finding. Open reduction, decompression and fixation are indicated in patients with posttraumatic stenosis and neurological weakness. Current operative methods include vertebroplasty and kyphoplasty, which significantly reduce pain and improve mobility of the patient and consequently, the quality of life.     

Pharmacologically active polymers, 23. Linear and branched zwitterionic derivatives of polyethyleneimine as carriers for pharmacologically active components

To obtain a carrier polymer for pharmacologically active components, linear polyethyleneimine (LPEI) was chemically modified by reactions with acrylic acid (1a) , acrylamide (1b) , acrylic acid esters (1c and 1d) , sodium chloroacetate, and hydrochloric acid. All product polymers 2a – 2e are soluble in water. Among these, 2a and 2e , β- and α-amino acid derivatives, respectively, show no acute toxicity in mice up to dosages of 1 g/kg i. v. Similar types of polymers 5a and 5b and a polymer containing phosphonic acid moieties (5d) derived from branched polyethyleneimine (BPEI) were prepared. 5a and 5b are also nontoxic regardless of the molecular weight of four kinds of BPEI and of the wide range of carboxylic group content in the polymer. It is suggested that the zwitterion form contributes to the nontoxic nature of β-and α-amino acid type polymers. The present results show that amino acid type polymers derived from LPEI and BPEI can be used as carrier polymers for pharmacologically active components.